| 000 | 13116nam a22004694a 4500 | ||
|---|---|---|---|
| 001 | ssj0000332677 | ||
| 003 | WaSeSS | ||
| 005 | 20200730155230.0 | ||
| 006 | m d | ||
| 007 | cr n | ||
| 008 | 080528s2009 caua obe 001 0 eng d | ||
| 020 |
_a9781412950848 _qcloth : alk. paper |
||
| 020 |
_a1412950848 _qcloth : alk. paper |
||
| 035 | _a(WaSeSS)ssj0000332677 | ||
| 040 |
_aDNLM/DLC _cDLC _dBTCTA _dBAKER _dYDXCP _dNLM _dNOR _dC#P _dOCLCQ _dUKM _dDLC _dWaSeSS |
||
| 042 | _apcc | ||
| 082 | 0 | 0 |
_a362.2903 _222 |
| 245 | 0 | 0 |
_aEncyclopedia of substance abuse prevention, treatment, & recovery _h[electronic resource] / _cGary L. Fisher, Nancy A. Roget, editors. |
| 246 | 3 | _aEncyclopedia of substance abuse prevention, treatment, and recovery. | |
| 260 |
_aLos Angeles : _bSAGE, _cc2009. |
||
| 300 |
_a2 v. (xxxiii, 1092 p.) : _bill. ; _c29 cm. |
||
| 500 | _a"A SAGE reference publication." | ||
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | 0 | 0 |
_gv. 1 -- _tList of entries -- _tReader's guide -- _tAbout the editors -- _tContributors -- _tIntroduction -- _tEntries -- _gv. 2 -- _tList of entries -- _tReader's guide -- _tEntries -- _tAppendix : Entries related to specific drugs -- _tIndex. |
| 505 | 0 | 0 |
_tAbstinence -- _tAbstinence violation effect -- _tAcamprosate -- _tAcceptance and commitment therapy -- _tAccess to recovery -- _tAddiction, models of -- _tAddiction severity index -- _tAddiction technology transfer centers -- _tAdolescents, substance abuse and treatment -- _tAdult children of alcoholics -- _tAfrican Americans, issues in prevention and treatment -- _tAftercare -- _tAl-Anon -- _tAlateen -- _tAlcohol -- _tAlcoholic personality -- _tAlcoholics Anonymous -- _tAlcohol-induced disorders -- _tAlcoholism -- _tAlcohol marketing -- _tAlcohol-related birth defects -- _tAlcohol testing -- _tAlcohol Use Disorders Identification Test -- _tAlternative activities -- _tAmerican Society of Addiction Medicine -- _tAmotivational syndrome -- _tAmphetamines -- _tAmyl nitrite -- _tAnabolic steroids -- _tAnorexia nervosa -- _tAntabuse (disulfiram) -- _tAntianxiety agents -- _tAntidepressant drugs -- _tAntipsychotic drugs -- _tAntiseizure drugs -- _tAntisocial personality disorder -- _tAnxiety disorders -- _tAnxiolytic drugs -- _tAsian Americans/Pacific Islanders, issues in prevention and treatment -- _tAssessment -- _tAssessment instruments -- _tAthletes and drug use -- _tAttention deficit hyperactivity disorder -- _tAversive conditioning -- _tAversive therapy -- |
| 505 | 0 | 0 |
_tBarbiturates -- _tBehavioral couples therapy -- _tBehavior risk factor surveillance system -- _tBehavioral therapy -- _tBenzodiazephines -- _tBiculturalism -- _tBig book, the -- _tBill W. -- _tBinge drinking -- _tBiopsychosocial model of addiction -- _tBlood alcohol concentration -- _tBorderline personality disorder -- _tBrain chemistry and addiction -- _tBrief interventions -- _tBrief strategic family therapy -- _tBulimia nervosa -- _tBuprenorphine -- _tBusiness improvement practices -- _tCaffeine -- _tCAGE screening instrument -- _tCannabinols -- _tCannabis youth treatment study -- _tCENAPS model -- _tCenter for Substance Abuse Prevention -- _tCenter for Substance Abuse Treatment -- _tCenters for the Application of Prevention Technologies -- _tCentral nervous system depressants -- _tCentral nervous system stimulants -- _tCertification and licensing -- _tChemical dependency -- _tChildren of alcoholics -- _tChronicity -- _tClient engagement -- _tClient/treatment matching -- _tClinical supervision of addiction counselors -- _tClub drugs -- _tCoalcoholic -- _tCocaine and crack -- _tCocaine Anonymous -- _tCodependency -- _tCoercion and treatment -- _tCognitive behavioral therapy -- _tCognitive-social learning model -- _tCollege on Problems of Drug Dependence -- _tCollege students, alcohol use and abuse -- _tCollege students, drug use and abuse -- _tCOMBINE study -- |
| 505 | 0 | 0 |
_tCommunity-based processes -- _tCommunity reinforcement and family training -- _tCommunity reinforcement approach -- _tComprehensive Drug Abuse Prevention and Control Act of 1970 (Public Law 91-513) -- _tConfidentiality -- _tContingency management -- _tContinuum of care -- _tCo-occurring disorders -- _tCounseling approaches -- _tCourt-mandated treatment -- _tCovert sensitization -- _tCrack -- _tCraving -- _tCrime and substance abuse -- _tCriminal justice populations -- _tCross-addictions -- _tCultural aspects -- _tDecriminalization -- _tDemand reduction -- _tDenial -- _tDepression -- _tDetoxification -- _tDiagnosis -- _tDiagnostic and Statistical Manual of Mental Disorders -- _tDisabilities, issues in prevention and treatment -- _tDiscrimination, addicted and recovering individuals -- _tDisease concept -- _tDouble trouble -- _tDriving under the influence -- _tDriving while intoxicated -- _tDrug abuse -- _tDrug abuse resistance education -- _tDrug abuse screening test -- _tDrug abuse treatment outcome studies -- _tDrug abuse warning network -- _tDrug addiction -- _tDrug courts -- _tDrug-crime cycle -- _tDrug-free Schools and Communities Act -- _tDrug laws, history of -- |
| 505 | 0 | 0 |
_tDrugs, classification of -- _tDrug testing -- _tDrug use, history of -- _tDry drunk syndrome -- _tDual relationships -- _tEating disorders -- _tEconomic costs of alcohol and drug abuse -- _tEcstasy -- _tElderly populations, treatment issues -- _tElectronic health records -- _tEmpirically based prevention -- _tEmpirically based treatment -- _tEmployee Assistance Program -- _tEnabling -- _tEnvironmental approaches -- _tEthical standards for addiction professionals -- _tEthics -- _tEvidence-based prevention -- _tEvidence-based prevention and treatment, dissemination and adoption of -- _tEvidence-based treatment -- _tExpectancies -- _tExperimental substance use -- _tFamily behavior therapy -- _tFamily counseling -- _tFamily therapy -- _tFentanyl -- _tFetal alcohol syndrome -- _tFetal effects of alcohol and other drugs -- _tFidelity of prevention programs -- |
| 505 | 0 | 0 |
_tGamblers Anonymous -- _tGambling, pathological -- _tGambling, problem -- _tGateway drugs theory -- _tGay, lesbian, bisexual, and transgender issues -- _tGender issues -- _tGenetic aspects of addiction -- _tGrief, loss, and substance abuse -- _tGroup therapy and counseling -- _tHallucinogens -- _tHarm reduction, public health -- _tHarm reduction psychotherapy -- _tHashish -- _tHealth care system and substance abuse -- _tHealth Insurance Portability and Accountability Act -- _tHepatitis C -- _tHeroin -- _tHigh-risk behaviors -- _tHigh-risk situations -- _tHispanics/Latinos, issues in prevention and treatment -- _tHIV/AIDS -- _tHomeless, substance abuse and treatment -- _tIssues in prevention ; racial and ethnic minorities -- _tIssues in treatment -- _tIce -- _tIllicit and illegal drugs -- _tImpaired professionals -- _tIndian health services -- _tInformation dissemination -- _tInformed consent -- _tInhalants -- _tInjection drug use -- _tInpatient treatment -- _tInstitute of Medicine Classification System -- _tInternational Coalition for Addiction Studies Education -- _tInternet addiction -- _tIntervention -- _tIntravenous drug use -- _tInventory of drinking situations -- |
| 505 | 0 | 0 |
_tJellinek, E.M. -- _tJohnson model intervention --- _tJoin Together -- _tLegal Action Center -- _tLegalization of drugs -- _tLevo-alpha acetyl methadol -- _tMarijuana -- _tMaternal drug use -- _tMatrix model -- _tMedia campaigns -- _tMedical consequences -- _tMedical use of marijuana -- _tMentoring -- _tMethadone -- _tMethadone maintenance treatment -- _tMethamphetamine -- _tMethods of drug administration -- _tMichigan Alcohol Screening Test -- _tMinnesota model -- _tModeration approaches to alcohol problems -- _tModeration in use -- _tModeration management -- _tMonitoring the future -- _tMoral model -- _tMorphine -- _tMotivational enhancement therapy -- _tMotivational interviewing -- _tMulticulturalism -- _tMultidimensional family therapy -- |
| 505 | 0 | 0 |
_tNAADAC, the Association for Addiction Professionals -- _tNaloxone -- _tNaltrexone -- _tNarcotics Anonymous -- _tNational Clearinghouse for Alcohol and Drug Information -- _tNational Council on Alcoholism and Drug Dependence -- _tNational Council on Problem Gambling -- _tNational Drug Control Strategy -- _tNational Epidemiologic Survey on Alcohol and Related Conditions -- _tNational Gambling Impact Study Commission -- _tNational Institute of Mental Health -- _tNational Institute on Alcohol Abuse and Alcoholism -- _tNational Institute on Drug Abuse -- _tNational Institute on Drug Abuse Clinical Trials Network -- _tNational media campaign -- _tNational outcome measures -- _tNational Registry of Evidence-based Programs and Practices -- _tNational Survey on Drug Use and Health -- _tNational Treatment Improvement Evaluation Study -- _tNative Americans, issues in prevention and treatment -- _tNatural recovery -- _tNeedle exchange programs -- _tNetwork for the improvement of addiction treatment -- _tNeurobiology of addiction -- _tNeurocognitive effects of alcohol and other drugs -- _tNeurotransmitters -- _tNicotine -- _tNicotine replacement therapy -- |
| 505 | 0 | 0 |
_tOffice of National Drug Control Policy -- _tOpiates -- _tOpioids -- _tOther addictions -- _tOutpatient treatment -- _tOver-the-counter drugs -- _tOxyContin -- _tPain management -- _tPatient placement criteria -- _tPeer recovery support services -- _tPharmacological approaches to treatment -- _tPhysiological aspects of drug use -- _tPost-traumatic stress disorder -- _tPrescription drugs -- _tPrevention education -- _tPrevention evaluation -- _tPrevention populations -- _tPrevention programs -- _tPrevention strategies -- _tProblem identification and referral -- _tProblem oriented screening instrument for teenagers -- _tProject MATCH -- _tPsychological models of addiction -- _tPsychosocial history -- _tPublic policy, alcohol -- _tPublic policy, drugs -- _tPublic policy, prevention -- _tPublic policy, treatment -- _tPulse check -- _tQualified services organization agreements -- _tRacial and ethnic minorities, issues in alcohol and other drug use -- _tRacial and ethnic minorities, issues in prevention -- _tRapid opioid detoxification -- _tRational recovery -- _tRecovery -- _tRecovery community organizations -- _tRecovery community services program -- _tRecovery schools -- _tRecovery support services -- _tRefusal skills -- _tRelapse -- _tRelapse prevention -- _tResearch issues in prevention -- _tResearch issues in treatment -- _tResidential treatment -- _tResistance in treatment -- _tReverse tolerance -- _tRisk and protective factor theory -- _tRisk factors for addiction -- _tRoutes of administration of drugs -- |
| 505 | 0 | 0 |
_tSchool-based prevention programs -- _tSchool drug policies -- _tScope of practice -- _tScreening -- _tScreening instruments -- _tSecular organizations for sobriety/Save Our Selves -- _tSedative-hypnotics -- _tSelf-change -- _tSelf-help groups -- _tSelf-report inventories -- _tSex addiction -- _tSexually transmitted diseases -- _tShopping addiction -- _tSingle state authorities -- _tSobriety -- _tSocial drinking -- _tSocial learning model of addictive behaviors -- _tSocial norms marketing -- _tSocial skills training -- _tSociocultural models of addiction -- _tSolution-focused therapy -- _tSpecial populations -- _tSpiritual issues -- _tSpontaneous remission -- _tStages of change model -- _tState provider associations -- _tSTD -- _tSteroids -- _tStigma -- _tStudent assistance program -- _tSubstance abuse -- _tSubstance abuse and mental health services administration -- _tSubstance abuse subtle screening inventory-3 -- _tSubstance dependence -- _tSubstance-induced disorders -- _tSubstance-induced withdrawal delirium -- _tSubstance use disorders -- _tSubstitute addictions -- _tSuicide -- _tSupply reduction -- _tSupport groups -- _tSynanon -- _tSynar amendment -- |
| 505 | 0 | 0 |
_tTherapeutic communities -- _tTimeline followback -- _tTobacco -- _tTobacco cessation programs and treatments -- _tTobacco marketing and countermarketing -- _tTobacco master settlement agreement -- _tTolerance -- _tTreatment, history of -- _tTreatment, nontraditional approaches -- _tTreatment access and retention -- _tTreatment approaches and strategies -- _tTreatment effectiveness -- _tTreatment facilities -- _tTreatment in jails and prisons -- _tTreatment of alcohol and drug use disorders -- _tTreatment plans and treatment planning -- _tTreatment programs for alcohol or drug abuse -- _tTreatment settings -- _tTuberculosis -- _tTwelve-step facilitation -- _tTwelve-step recovery programs -- _tTwelve steps -- _tUnderage drinking -- _tUrine toxicology testing -- _tVeterans, substance abuse and treatment -- _tViolence, intimate partner and substance abuse treatment -- _tViolence prevention -- _tWar on drugs -- _tWelfare reform and substance abuse -- _tWillpower -- _tWithdrawal -- _tWomen for sobriety -- _tWomens' issues in prevention and treatment -- _tWorkplace drug policies -- _tWorkplace drug use -- _tWorkplace prevention. |
| 538 | _aAvailable electronically via the Internet. | ||
| 650 | 0 |
_aSubstance abuse _vEncyclopedias. |
|
| 653 | _aSubstance-Related Disorders | ||
| 700 | 1 | _aFisher, Gary L. | |
| 700 | 1 | _aRoget, Nancy A. | |
| 856 | 4 | 0 |
_uhttp://wallaby.vu.edu.au:2048/login?url=http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=e000xww&AN=474383 _zFull text available from eBook Academic Subscription Collection - Worldwide |
| 942 |
_2ddc _cE-BOOK |
||
| 999 |
_c35663 _d35663 |
||